Skip to main content
Fig. 3 | BMC Neuroscience

Fig. 3

From: Neuroprotective effects of HTR1A antagonist WAY-100635 on scopolamine-induced delirium in rats and underlying molecular mechanisms

Fig. 3

Expression of neurotransmitter receptors in different delirium-associated brain regions of control rats before and after scopolamine treatment. a Protein levels of neurotransmitter receptors were detected by western blot, b quantitative analysis of blots by densitometry, c mRNA level of neurotransmitters determined by qPCR; ***p < 0.001 by comparison against other neurotransmitter receptors

Back to article page